标题
Novel therapies based on the pathophysiology of atopic dermatitis
作者
关键词
-
出版物
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
Volume 17, Issue 11, Pages 1150-1162
出版商
Wiley
发表日期
2019-11-25
DOI
10.1111/ddg.13965
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Application of Topical Phosphodiesterase 4 Inhibitors in Mild to Moderate Atopic Dermatitis
- (2019) Huan Yang et al. JAMA Dermatology
- Janus kinases to jakinibs: from basic insights to clinical practice
- (2019) Massimo Gadina et al. RHEUMATOLOGY
- Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial
- (2019) Sonja Ständer et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis
- (2019) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Understanding the Immune Landscape in Atopic Dermatitis: The Era of Biologics and Emerging Therapeutic Approaches
- (2019) Matthew Moyle et al. EXPERIMENTAL DERMATOLOGY
- Current and emerging therapies for hand eczema
- (2019) Griffin R. Lee et al. Dermatologic Therapy
- The oral Janus kinase/spleen tyrosine kinase inhibitor ASN 002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study
- (2019) R. Bissonnette et al. BRITISH JOURNAL OF DERMATOLOGY
- Interleukin‐13: Targeting an underestimated cytokine in atopic dermatitis
- (2019) Thomas Bieber ALLERGY
- Pharmacological development in hidradenitis suppurativa
- (2019) Łukasz Matusiak et al. CURRENT OPINION IN PHARMACOLOGY
- European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period
- (2019) C. Vestergaard et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb
- (2018) Andreas Wollenberg et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis
- (2018) Nick Vandeghinste et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- New therapies for atopic dermatitis: Additional treatment classes
- (2018) Paras P. Vakharia et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Emerging therapies for atopic dermatitis: JAK inhibitors
- (2018) David G. Cotter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A Phase 2, Randomized Dose-Finding Study of Tapinarof (GSK2894512 Cream) for the Treatment of Atopic Dermatitis
- (2018) Johnny Peppers et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial
- (2018) Gil Yosipovitch et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial
- (2018) Emma Guttman-Yassky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)
- (2018) Eric L. Simpson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The human skin microbiome
- (2018) Allyson L. Byrd et al. NATURE REVIEWS MICROBIOLOGY
- Atopic dermatitis
- (2018) Stephan Weidinger et al. Nature Reviews Disease Primers
- A Phase 2 Randomized Trial of Apremilast in Patients With Atopic Dermatitis
- (2018) Eric Simpson et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Tezepelumab, an anti-TSLP monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial
- (2018) Eric L. Simpson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Targeting Costimulatory Pathways in Systemic Sclerosis
- (2018) Gonçalo Boleto et al. Frontiers in Immunology
- The atopic march: current insights into skin barrier dysfunction and epithelial cell-derived cytokines
- (2017) Hongwei Han et al. IMMUNOLOGICAL REVIEWS
- Therapeutic pipeline for atopic dermatitis: End of the drought?
- (2017) Amy S. Paller et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis
- (2017) Thomas Ruzicka et al. NEW ENGLAND JOURNAL OF MEDICINE
- Panimmunoglobulin and IgE-selective extracorporeal immunoadsorption in patients with severe atopic dermatitis
- (2016) Kristian Reich et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy of omalizumab in patients with atopic dermatitis: A systematic review and meta-analysis
- (2016) Hsiao-Han Wang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Spontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunity
- (2016) Sean P. Saunders et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults
- (2016) Amy S. Paller et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The aryl hydrocarbon receptor AhR links atopic dermatitis and air pollution via induction of the neurotrophic factor artemin
- (2016) Takanori Hidaka et al. NATURE IMMUNOLOGY
- Barrier Epithelial Cells and the Control of Type 2 Immunity
- (2015) Hamida Hammad et al. IMMUNITY
- The Janus-Faced Role of Aryl Hydrocarbon Receptor Signaling in the Skin: Consequences for Prevention and Treatment of Skin Disorders
- (2015) Thomas Haarmann-Stemmann et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The histamine H4 receptor: from orphan to the clinic
- (2015) Robin L. Thurmond Frontiers in Pharmacology
- Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects
- (2014) J. P. Arm et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Novel histamine H4receptor ligands and their potential therapeutic applications: an update
- (2014) Róbert Kiss et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
- (2014) Lisa A. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased efficacy of omalizumab in atopic dermatitis patients with wild-type filaggrin status and higher serum levels of phosphatidylcholines
- (2013) M. Hotze et al. ALLERGY
- Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis
- (2012) H. H. Kong et al. GENOME RESEARCH
- IL-33: A Novel Danger Signal System in Atopic Dermatitis
- (2012) Ferda Cevikbas et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- TSLP Produced by Keratinocytes Promotes Allergen Sensitization through Skin and Thereby Triggers Atopic March in Mice
- (2012) Juan Manuel Leyva-Castillo et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Regulation of epithelial immunity by IL-17 family cytokines
- (2012) Rajita Pappu et al. TRENDS IN IMMUNOLOGY
- Interleukin-22 downregulates filaggrin expression and affects expression of profilaggrin processing enzymes
- (2011) D. Gutowska-Owsiak et al. BRITISH JOURNAL OF DERMATOLOGY
- Omalizumab-Therapie atopischer Dermatitis: IgE-Depletion führt nicht zur klinischen Besserung - eine randomisierte, placebo-kontrollierte, doppelblinde Pilotstudie
- (2010) Peter Maximilian Heil et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Atopic Dermatitis
- (2008) Thomas Bieber NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now